Concord, NC, United States
Mckesson Packaging Services recalls
3 recalls recorded since 2018, most recently on 23 April 2018. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls3
Ongoing (FDA)0
Terminated or completed3
Class I (FDA)0
Terminated Class III Drugs
- Recall started
- 23 April 2018
- Terminated
- 13 October 2020
- Reason
- Failed Dissolution Specifications. High dissolution results were obtained during stability testing.
- Distribution
- Nationwide with the US
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0715-2018, D-0716-2018, D-0714-2018
- Diltiazem CD (Diltiazem Hydrochloride Extended-Release Capsules, USP) 180 mg, 100-count bottles, Rx Only Mfg. By: Actavis 60 Columbia Rd., Bldg. B Morristown, NJ 07960. NDC 63739-284-10
- Diltiazem HCl Extended-Release Capsules, USP 240 mg, 100-count bottles, Rx Only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977. NDC: 63739-016-10
- Diltiazem HCl Extended-Release Capsules, USP 120 mg, 100-count bottles, Rx only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977. NDC: 63739-014-10
Terminated Class II Drugs
- Recall started
- 26 February 2018
- Terminated
- 15 September 2020
- Reason
- Failed Stability Specifications
- Distribution
- Nationwide
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0914-2018
- RANITIDINE Tablets, USP 150 mg UD 100 tablets (10x10), RX Only, Manufactured by: Amneal Pharmaceuticals, Hauppauge, NY 11788, NDC 63739-489-10
Terminated Class III Drugs
- Recall started
- 29 January 2018
- Terminated
- 24 November 2020
- Reason
- Subpotent Drug: Out of specification for assay (stability testing)
- Distribution
- U.S.A. Nationwide
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0338-2018
- Megestrol Acetate Oral Suspension, USP 400 mg/ 10mL (10 mL UD cups in boxes of 20 cups), Rx Only, Dist. By McKesson Packaging Services a business unit of McKesson Corporation 7101 Weddington Rd. Concord, NC 28027, NDC 63
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.